Stockreport

RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF PLK1 is a protein kinase that plays a crucial role in cellular mitosis and is overexpressed in various cancers. The platform was used to analyze the interactions between [Read more]